Aquestive Therapeutics (AQST) Other Working Capital Changes (2017 - 2026)

Aquestive Therapeutics' Other Working Capital Changes history runs 10 years deep, the most recent figure standing at -$272000.0 for Q1 2026.

• In Q1 2026, Other Working Capital Changes fell 4.21% year-over-year to -$272000.0; the TTM figure through Mar 2026 stood at -$1.5 million (up 88.5% YoY), while the FY2025 annual figure was -$571000.0, up 95.55% from the prior year.
• Other Working Capital Changes was -$272000.0 for Q1 2026 at Aquestive Therapeutics, roughly flat from -$272000.0 in the prior quarter.
• In the past five years, Other Working Capital Changes ranged from a high of $14.5 million in Q4 2022 to a low of -$11.8 million in Q4 2024.
• Historically, Other Working Capital Changes has averaged $536058.8 across 5 years, with a median of -$73000.0 in 2023.
• The sharpest annual moves came in 2023 and 2024: Other Working Capital Changes surged 2019.13% in 2023, then slumped 16009.59% in 2024.
• A 5-year view of Other Working Capital Changes shows it stood at $14.5 million in 2022, then slumped by 100.5% to -$73000.0 in 2023, then plunged by 16009.59% to -$11.8 million in 2024, then soared by 97.69% to -$272000.0 in 2025, then changed by 0.0% to -$272000.0 in 2026.
• The last three Other Working Capital Changes figures came in at -$272000.0 (Q1 2026), -$272000.0 (Q4 2025), and -$1.2 million (Q3 2025), per Business Quant data.